Found 50 matching trials
Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study PHASE4 The current project proposes the comparison of two pharmacologic strategies...
Show More Location
Fundació LLuita contra la SIDA
Learn More & Join Trial
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease PHASE3 The purpose of this study is to assess the efficacy, safety, and tolerabili...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients PHASE3 The purpose of this study is to determine whether a exercise program when c...
Show More Location
Ferderal University of Bahia - DINEP
Learn More & Join Trial
Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease PHASE4 This study used two doses of rivastigmine transdermal patch (5 cm\^2, 10 cm...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease PHASE3 The purpose of this study was to investigate the 5cm\^2 and 10cm\^2 doses o...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia PHASE4 This phase IIIb study is intended to implement a consistent treatment way f...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Electrophysiologic Measures of Treatment Response in Alzheimer Disease PHASE4 The main purpose of this study is to determine the electrophysiological eff...
Show More Location
Department of Veterans Affairs
Learn More & Join Trial
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 PHASE4 The core study assessed the efficacy of a higher dose of rivastigmine 13.3 ...
Show More Location
Clinical Research Advantage Inc./Neurological. Physicians of Arizona, Inc
Learn More & Join Trial
Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine NA The purpose of this study is to evaluate and compare the changes of cogniti...
Show More Location
Holy Family Hospital, The Catholic Univerisy of Korea, School of Medicine
Learn More & Join Trial
Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine PHASE4 The goal of this clinical trial is to test the beneficial effects of rivast...
Show More Learn More & Join Trial